Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

444213 MMP-2, Proenzyme, Human Rheumatoid Synovial Fibroblast

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Matrix Metalloproteinase 2, Gelatinase A, 72 kDa Type IV Collagenase

View Products on Sigmaaldrich.com
444213
Purchase on Sigma-Aldrich

Overview

Replacement Information

Products

Catalogue NumberPackaging Qty/Pack
444213-5UGCN Plastic ampoule 5 μg
Description
OverviewNative pro-MMP-2 from cultured, human rheumatoid synovial fibroblasts. Secreted by several cell types. Requires activation just prior to use.
Note: 1 mU = 1 milliunit.
Catalogue Number444213
Brand Family Calbiochem®
SynonymsMatrix Metalloproteinase 2, Gelatinase A, 72 kDa Type IV Collagenase
References
ReferencesBuisson-Leqendre, N., et al. 2004. Arth. Rheumat. 50, 2151.
Morgunova, E., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 7414.
Kolkenbrock, H., et al. 1997. Biol. Chem. 378, 71.
Product Information
Unit of DefinitionOne unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol 2,4-DNP-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg-OH per min at 37°C, pH 7.0.
EC number3.4.24.24
FormLiquid
FormulationIn 200 mM NaCl, 50 mM Tris-HCl, 5 mM CaCl₂, 1 µM ZnCl₂, 0.05% BRIJ® 35 Detergent, 0.05% NaN₃, pH 7.0.
Quality LevelMQ100
Applications
Biological Information
Purity≥90% by SDS-PAGE
SourcePrepared from culture medium of human rheumatoid synovial fibroblasts that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
Specific Activity≥600 mU/mg protein
Concentration Label Please refer to vial label for lot-specific concentration
Physicochemical Information
Contaminantsno other MMP activity detectable
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Dry Ice Only
Toxicity Standard Handling
Storage ≤ -70°C
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
444213-5UGCN 04055977205190

Documentation

MMP-2, Proenzyme, Human Rheumatoid Synovial Fibroblast SDS

Title

Safety Data Sheet (SDS) 

MMP-2, Proenzyme, Human Rheumatoid Synovial Fibroblast Certificates of Analysis

TitleLot Number
444213

References

Reference overview
Buisson-Leqendre, N., et al. 2004. Arth. Rheumat. 50, 2151.
Morgunova, E., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 7414.
Kolkenbrock, H., et al. 1997. Biol. Chem. 378, 71.

Citations

Title
  • Feng Zheng, et al. (2004) Development of albuinuria and glomerular lesions in normoglycemic B6 recepients of db/db mice bone marrow. Diabetes 53, 2420-2427.
    		•
    Data Sheet

    Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

    Revision18-July-2007 RFH
    SynonymsMatrix Metalloproteinase 2, Gelatinase A, 72 kDa Type IV Collagenase
    DescriptionNative pro-MMP-2 from cultured, human rheumatoid synovial fibroblasts. Highly purified native enzyme derived from cell culture. Secreted by several cell types. Exists in a stable, but non-covalent 1:1 complex with TIMP-2. Requires activation prior to use.
    FormLiquid
    FormulationIn 200 mM NaCl, 50 mM Tris-HCl, 5 mM CaCl₂, 1 µM ZnCl₂, 0.05% BRIJ® 35 Detergent, 0.05% NaN₃, pH 7.0.
    Concentration Label Please refer to vial label for lot-specific concentration
    Recommended reaction conditions

    Organomercurial Activation Protocol This protocol is provided only as a general guide. Researchers should standardize this assay for their own specific needs and should consult published literature. The following protocol is from Stricklin, et al., which describes the use of p-aminophenylmercuric acetate (APMA) to activate pro-MMP. This protocol is also adaptable to other types of organomercurals, such as p-(hydroxymercuric) benzoate (PHMB), phenylmercuric chloride (PMC), or mersalyl. 1. Prepare a 10-50 mM stock solution of APMA (or other organomercurial compound) in 0.1 M NaOH just prior to use. Although not absolutely necessary, the stock solution may be adjusted to pH 11 with 5 N HCl (see Marcy, A.I., et al.). 2. To initiate the activation mix the proenzyme solution with the APMA solution at a 10:1 volume ratio (MMP:APMA). If a higher concentration of APMA is desired, increase the concentration of the stock solution. Do not exceed the 10:1 ratio, as this could result in significant changes in pH. 3. Incubate the mixture at 37°C for 2-3 h. It is recommended that an analytical run be conducted first to determine the optimal incubation time. For example, a small-scale experiment with a fixed concentration of pro-MMP and organomercurial would be incubated as described above. Remove aliquots of the sample at various time points during the incubation. Stop the reaction by the addition of SDS-PAGE sample buffer (e.g., 10 µl 2X sample buffer to 10 µl aliquot) and heat the samples to 95°C. The progress of activation can be monitored qualitatively by analyzing the aliquots on a 12% SDS-PAGE gel. 4. The activated MMP can be used without removing the APMA from the mixture. Please refer to Marcy, A.I., et al. for removal of organomercurials by gel filtration.
    SourcePrepared from culture medium of human rheumatoid synovial fibroblasts that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
    EC number3.4.24.24
    Purity≥90% by SDS-PAGE
    Contaminantsno other MMP activity detectable
    Specific activity≥600 mU/mg protein
    Unit definitionOne unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol 2,4-DNP-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg-OH per min at 37°C, pH 7.0.
    SolubilityAqueous buffers
    Storage Avoid freeze/thaw
    ≤ -70°C
    Do Not Freeze Ok to freeze
    Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
    Toxicity Standard Handling
    ReferencesBuisson-Leqendre, N., et al. 2004. Arth. Rheumat. 50, 2151.
    Morgunova, E., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 7414.
    Kolkenbrock, H., et al. 1997. Biol. Chem. 378, 71.
    Citation
  • Feng Zheng, et al. (2004) Development of albuinuria and glomerular lesions in normoglycemic B6 recepients of db/db mice bone marrow. Diabetes 53, 2420-2427.
    		•